Prospective, randomized, open-label,clinical trial comparing the effects of azilsartan and amlodipine on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseases
Latest Information Update: 20 May 2020
At a glance
- Drugs Amlodipine (Primary) ; Azilsartan (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 29 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by UMIN record.
- 17 Sep 2013 New trial record